Efficacy and safety of acetylcysteine for the prevention of liver injury in COVID-19 intensive care unit patients under treatment with remdesivir
Sign Up to like & getrecommendations! Published in 2022 at "Gastroenterology and Hepatology From Bed to Bench"
DOI: 10.22037/ghfbb.v15i3.2565
Abstract: Aim: The present double-blinded placebo-controlled randomized clinical trial evaluated prophylactic use of acetylcysteine for the prevention of liver injury in patients with severe COVID-19 pneumonia under treatment with remdesivir. Background: Liver injury is reportedly common… read more here.
Keywords: acetylcysteine; liver injury; treatment remdesivir; acetylcysteine prevention ... See more keywords